Overview

Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study

Status:
Completed

Trial end date:
2015-05-11

Target enrollment:

Participant gender:

Summary

The purpose of this study is to examine whether the VPA (Valproate) dose can be reduced by additional administration of LTG (Lamotrigine) in Japanese pre-menopausal female epilepsy patients aged 15 years or older, whose seizures are well controlled by VPA monotherapy.

Phase:

Phase 4

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Anticonvulsants
Lamotrigine
Valproic Acid